LexDanaLexDanabeta
Inventor

MARTIN W. ROWBOTTOM

Inventor
US

Overview

3→
Patents
2022
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds10%
PatentTitleYear
11,459,309Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making202211,358,936Lysyl oxidase-like 2 inhibitors and uses thereof202211,345,676Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to PHARMAKEA INC (3)· patent assignee history
2022Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PHARMAKEA INC32022
Locations
LocationPatentsSpan
US32022